Primecap Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-76,030
| Closed | -$389K | – | 330 |
|
|
2024
Q3 | $389K | Sell |
76,030
-70,160
| -48% | -$359K | ﹤0.01% | 330 |
|
|
2024
Q2 | $529K | Hold |
146,190
| – | – | ﹤0.01% | 326 |
|
|
2024
Q1 | $469K | Hold |
146,190
| – | – | ﹤0.01% | 329 |
|
|
2023
Q4 | $716K | Hold |
146,190
| – | – | ﹤0.01% | 325 |
|
|
2023
Q3 | $797K | Hold |
146,190
| – | – | ﹤0.01% | 319 |
|
|
2023
Q2 | $981K | Hold |
146,190
| – | – | ﹤0.01% | 314 |
|
|
2023
Q1 | $1.29M | Hold |
146,190
| – | – | ﹤0.01% | 307 |
|
|
2022
Q4 | $1.12M | Sell |
146,190
-4,310
| -3% | -$32.9K | ﹤0.01% | 312 |
|
|
2022
Q3 | $1.07M | Hold |
150,500
| – | – | ﹤0.01% | 314 |
|
|
2022
Q2 | $1.22M | Sell |
150,500
-45,000
| -23% | -$364K | ﹤0.01% | 316 |
|
|
2022
Q1 | $2.71M | Sell |
195,500
-5,000
| -2% | -$69.4K | ﹤0.01% | 305 |
|
|
2021
Q4 | $5.63M | Sell |
200,500
-5,000
| -2% | -$140K | ﹤0.01% | 288 |
|
|
2021
Q3 | $6.99M | Sell |
205,500
-14,000
| -6% | -$476K | ﹤0.01% | 280 |
|
|
2021
Q2 | $8.97M | Buy |
219,500
+9,000
| +4% | +$368K | 0.01% | 265 |
|
|
2021
Q1 | $8.48M | Buy |
210,500
+82,000
| +64% | +$3.3M | 0.01% | 266 |
|
|
2020
Q4 | $7.6M | Sell |
128,500
-44,000
| -26% | -$2.6M | 0.01% | 268 |
|
|
2020
Q3 | $8.39M | Buy |
172,500
+22,000
| +15% | +$1.07M | 0.01% | 245 |
|
|
2020
Q2 | $7.28M | Hold |
150,500
| – | – | 0.01% | 237 |
|
|
2020
Q1 | $4.18M | Buy |
+150,500
| New | +$4.18M | ﹤0.01% | 244 |
|